Precision Neuroscience Stock

precisionneuro.ioHealthcare / BioTech & PharmaFounded: 2021

Precision Neurosciences is a biotechnology company focused on producing brain implants that improve conditions for individuals with neurological disorders. The private company has engineered high resolution electrode arrays that can act as a miniature computer and can easily be implanted through a minimally invasive procedure. Precision’s goal is to make its brain-computer interfaces available at scale for the millions of people who suffer from severe neurological conditions.

Register To Buy and Sell Shares

For more details on financing and valuation for Precision Neuroscience, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Precision Neuroscience’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Precision Neuroscience.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Michael Mager
Chief Executive Officer and Co-Founder
Demetrios Papageorgiou
Co-Founder and SVP of Engineering

Frequently Asked Questions About Precision Neuroscience’s Stock

plusminus
Can you buy Precision Neuroscience’s stock?
Precision Neuroscience is not publicly traded on NYSE or NASDAQ in the U.S. To buy Precision Neuroscience’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Precision Neuroscience’s stock?
Yes, you can sell stock of a private company like Precision Neuroscience. Forge can help you sell your Precision Neuroscience stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Precision Neuroscience’s stock price?
Precision Neuroscience is a privately held company and therefore does not have a public stock price. However, you may access Precision Neuroscience’s private market stock price with Forge Data.
plusminus
What is Precision Neuroscience’s stock ticker symbol?
Precision Neuroscience does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Precision Neuroscience launches new BCI study sites
Using a brain-computer interface, Precision Neuroscience is working towards understanding brain-controlled movement.
Precision Neuroscience Expands Clinical Research In Brain–Computer Interface
To help patients with paralysis, Precision Neuroscience is using a technological interface for brain signals.
Precision Neuroscience is making brain implants safer, smarter and reversible
Precision Neuroscience is building a modern brain implant that's not only an order of magnitude better, but far less invasive to put in.
Updated on: May 17, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.